Actinium Pharmaceuticals, Inc. announced the appointment of Avinash Desai, MD, to the position of Executive Vice President of Clinical Development, Operations and Medical Affairs, effective immediately. Â In this role, Dr. Desai will lead Actinium's medical affairs strategies for Iomab-B to the transplant and hematology communities as well as for Actimab-A to the hematologist communities. In addition, he will play an integral role in the strategic development of the Iomab-B clinical programs. Dr. Desai is an industry veteran in the hematology and oncology field, most recently serving as Vice President, Head of U.S. Medical Affairs Oncology at Glaxo Smith Kline (GSK). Over the course of his twenty-five-year career, Dr. Desai has successfully designed and implemented clinical development, U.S. and global medical affairs, and life cycle management plans for a variety of pharmaceutical products.